» Articles » PMID: 20845010

Lymph Node Retrieval and Examination During the Implementation of Extended Lymph Node Dissection for Gastric Cancer in a Non-specialized Western Institution

Overview
Journal Updates Surg
Specialty General Surgery
Date 2010 Sep 17
PMID 20845010
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The optimal degree of lymph node dissection for gastric cancer is still matter of debate. Particularly, there are serious doubts about the reproducibility of extended lymph node dissection in western surgical units, and no studies to date have investigated factors influencing lymph node retrieval and examination during the learning curve. Univariate and multivariate retrospective analysis of 21 variables were carried out on a prospective series of 313 consecutive resections for gastric cancer performed by ten different surgeons, with lymph node retrieval and analysis performed by ten different pathologists. Endpoints were number of examined lymph nodes per patient, number of cases with inadequate nodal staging (<15 examined lymph nodes) and lymph node ratio (calculated as the absolute ratio between the number of metastatic and the number of examined lymph nodes). The number of examined lymph nodes per patient (mean ± SD 28.3 ± 14.1, median 26, range 2-78) was independently influenced by age, pN status, the type of gastric resection, the degree of lymph node dissection and single pathologist. There were 47 cases (15.0%) with incomplete nodal staging that was independently determined by the degree of lymph node dissection and by the pathologist. Lymph node ratio was independently influenced by the number of metastatic lymph nodes, the disease stage and by the histological subtype of the tumor. The role of an experienced or dedicated pathologist should not be underevaluated in western series when dealing with lymph node retrieval and examination. Lymph node ratio appeared not to be significantly influenced by the number of examined lymph nodes, being independently influenced only by the number of metastatic lymph nodes, the disease stage and by the histological subtype of the tumor. It could be therefore tested as a prognostic factor limiting the stage-migration phenomenon induced by extended lymph node dissection.

Citing Articles

Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients.

Chen Y, Lu J, Nie R, Liu D, Liu A, Deng Z Front Oncol. 2021; 11:593470.

PMID: 33996537 PMC: 8121255. DOI: 10.3389/fonc.2021.593470.


Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial.

Catarci M, Berlanda M, Grassi G, Masedu F, Guadagni S Gastric Cancer. 2017; 21(3):542-551.

PMID: 28804801 PMC: 5906500. DOI: 10.1007/s10120-017-0757-y.


N staging: the role of the pathologist.

De Marco C, Biondi A, Ricci R Transl Gastroenterol Hepatol. 2017; 2:10.

PMID: 28275742 PMC: 5334562. DOI: 10.21037/tgh.2017.01.02.


Lower serum folate is associated with development and invasiveness of gastric cancer.

Lee T, Chiang E, Shih Y, Lane H, Lin J, Wu C World J Gastroenterol. 2014; 20(32):11313-20.

PMID: 25170216 PMC: 4145770. DOI: 10.3748/wjg.v20.i32.11313.


Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer.

Catarci M, Montemurro L, Ghinassi S, Di Cintio A, Leone L, Cosentino L Updates Surg. 2011; 63(2):83-90.

PMID: 21445644 DOI: 10.1007/s13304-011-0065-8.

References
1.
McCulloch P, Niita M, Kazi H, Gama-Rodrigues J . Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg. 2005; 92(1):5-13. DOI: 10.1002/bjs.4839. View

2.
Noda N, Sasako M, Yamaguchi N, Nakanishi Y . Ignoring small lymph nodes can be a major cause of staging error in gastric cancer. Br J Surg. 1998; 85(6):831-4. DOI: 10.1046/j.1365-2168.1998.00691.x. View

3.
Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S . Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol. 2006; 93(5):394-400. DOI: 10.1002/jso.20495. View

4.
Hammond E, Henson D . The role of pathologists in cancer patient staging. Cancer Committee. Am J Clin Pathol. 1995; 103(6):679-80. DOI: 10.1093/ajcp/103.6.679. View

5.
LAUREN P . THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965; 64:31-49. DOI: 10.1111/apm.1965.64.1.31. View